Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases

被引：0
|
作者：
Elsa L. S. A. van Liere
Ahmed B. Bayoumy
Chris J. J. Mulder
Ben Warner
Bu Hayee
Bilal A. Mateen
Jonathan D. Nolan
Nanne K. H. de Boer
Simon H. C. Anderson
Azhar R. Ansari
机构：
[1] Amsterdam UMC,Faculty of Medicine
[2] VU University Medical Centre,Department of Gastroenterology and Hepatology
[3] Surrey and Sussex NHS,Department of Gastroenterology and Hepatology
[4] Easy Surrey Hospital,Department of Gastroenterology and Hepatology
[5] AGEM Research Institute,IBD Service
[6] Amsterdam UMC,undefined
[7] VU University Medical Centre,undefined
[8] Guy’s and St Thomas’ NHS Foundation Trust,undefined
[9] King’s College Hospital NHS Foundation Trust,undefined
来源：
Digestive Diseases and Sciences | 2022年 / 67卷
关键词：
Azathioprine; Allopurinol; Thiopurines; Inflammatory bowel disease; Drug repositioning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4008 / 4019
页数：11
相关论文
共 50 条
  • [1] Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases
    van Liere, Elsa L. S. A.
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Warner, Ben
    Hayee, Bu
    Mateen, Bilal A.
    Nolan, Jonathan D.
    de Boer, Nanne K. H.
    Anderson, Simon H. C.
    Ansari, Azhar R.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4008 - 4019
  • [2] Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease
    Ansari, A. R.
    Aziz, A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 97 - 98
  • [3] First-Line Therapies in Inflammatory Bowel Disease
    Girardin, Marc
    Manz, Michael
    Manser, Christine
    Biedermann, Luc
    Wanner, Roger
    Frei, Pascal
    Safroneeva, Ekaterina
    Mottet, Christian
    Rogler, Gerhard
    Schoepfer, Alain M.
    DIGESTION, 2012, 86 : 6 - 10
  • [4] Impact of first-line infliximab on the pharmacokinetics of second-line vedolizumab in inflammatory bowel diseases
    Liefferinckx, Claire
    Verstockt, Bram
    Gils, Ann
    Tops, Sophie
    Van Moerkercke, Wouter
    Vermeire, Severine
    Franchimont, Denis
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (06) : 750 - 758
  • [5] FIRST-LINE AZATHIOPRINE- ALLOPURINOL WITHOUT METABOLITE MONITORING IS AN EFFECTIVE AND SAFE LONG-TERM THERAPY FOR IBD
    Ansari, A.
    van Liere, Elisa
    Anderson, Simon
    Warner, Ben
    Hayee, Bu'
    Nolan, Jonathan
    de Boer, Nanne
    Mulder, Chris
    GUT, 2021, 70 : A129 - A129
  • [6] Biologicals first-line in chronic inflammatory bowel disease? No
    Herrlinger, K.
    Stange, E. F.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (36) : 1789 - 1789
  • [7] Editorial: an argument for low-dose thiopurine allopurinol combination use as first-line therapy in inflammatory bowel disease-authors' reply
    Friedman, A. B.
    Sparrow, M. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 98 - 99
  • [8] Azathioprine in the treatment of chronic inflammatory bowel diseases
    Herrlinger, K
    Stange, EF
    MEDIZINISCHE KLINIK, 2000, 95 (04) : 201 - 206
  • [9] Biologicals first-line in chronic inflammatory bowel disease? Yes
    Stallmach, A.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (36) : 1788 - 1788
  • [10] Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy
    Simseki, Cem
    Wahlin, Staffan
    Efe, Cumali
    JOURNAL OF HEPATOLOGY, 2024, 81 (01) : e41 - e42
12345